Pierre Sayad
Patrimonio netto: 210 347 $ in data 31/05/2026
Patrimonio netto: 210 347 $ in data 31/05/2026
Pierre S.
Sayad is currently Chief Medical Officer at Fennec Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Sayad was Senior Vice President-Global Medical Affairs at International Myeloma Foundation, Vice President-Global Medical & Scientific Affairs at Karyopharm Therapeutics, Inc., and Chief Operating & Medical Officer at Zephyr Group, Inc. Education includes graduate studies at Loma Linda University and undergraduate studies at San Jose State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2026 | 21.183 ( 0,06% ) | 210 347 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Direttore Tecnico/Scientifico/R&S | 28/10/2024 |
| Società | Posizione | Fine |
|---|---|---|
International Myeloma Foundation
International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Corporate Officer/Principal | - |
| KARYOPHARM THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Fennec Pharmaceuticals, Inc.
Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
International Myeloma Foundation
International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Commercial Services |
Loma Linda University
Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale